All posts by imreal

Northeast Delta HSA announces free-to-public 2023 Faith Summit set for May 20; event will equip spiritual leaders and professionals with mental health and addiction tools


Northeast Delta HSA announces free-to-public 2023 Faith Summit set for May 20

Northeast Delta HSA announces free-to-public 2023 Faith Summit set for May 20

“I believe that as a government agency, we can and are effectively helping our citizens meet many of their physical, behavioral health, financial, and social needs,” Dr. Sizer said.

Northeast Delta Human Services Authority (NEDHSA) announces its 2023 Faith Summit set for Saturday, May 20, 2023, at the University of Louisiana Monroe’s Bayou Pointe Event Center, with registration beginning at 8 a.m. The theme for the Faith Summit is “Using Faith to Reduce Fear: My New Future.” This event is part of NEDHSA’s Faith Partnership Initiatives to help spiritual leaders better understand the complexities and treatment options for those battling mental illness and addictions.

NEDHSA Executive Director Dr. Monteic A. Sizer said he “conceptualized our faith partnership initiative ten years ago to help faith leaders better understand the science, complexities, and treatment options available for those battling mental illness and addiction in their pulpits, congregations, homes, and communities.”

“I believe that as a government agency, we can and are effectively helping our citizens meet many of their physical, behavioral health, financial, and social needs,” Dr. Sizer said. “However, the government can’t solve complex societal problems alone.”

The Faith Summit will feature Dr. Sizer as the keynote speaker, four breakout sessions, a panel of faith-based leaders, and Peer Counselor Tonja Myles, a subject matter expert in mental health, substance abuse, and untreated trauma. In addition, the faith summit will provide opportunities for faith and spiritual influencers from various sectors and denominations to network and uncover solutions and resources to aid their parishioners who may be experiencing mental health and addiction disorders.

NEDHSA created partnerships with faith leaders and their congregations because they are uniquely positioned in society to help further NEDHSA’s efforts to stabilize traditional mental health services. Additionally, NEDHSA wants to educate, equip and provide resources to faith leaders to address substance abuse, prevention, support, and recovery needs in their congregations. The Faith Summit will also provide Continuing Education Units (CEUs) to industry professionals.

Dr. Sizer said, “various negative health outcomes are attributable to the interactions of traumatic experiences and social and political determinants of health.”

“The science is clear,” Dr. Sizer said. “What is unclear is whether human beings can do something about what is known consistently and long enough without God’s intervention. Just look at our nation and world.”

No-cost tickets are available via the following link: nedhsafaith2023.eventbrite.com

Share article on social media or email:

Mount Sinai Launches Institute for Regenerative Medicine


“The Institute for Regenerative Medicine is dedicated to making transformations in how we treat regenerative diseases that impact millions of lives,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System.

Regenerative medicine—the process of replacing, engineering or regenerating human cells, tissues or organs—holds exciting potential for the field of health care. It could someday make it possible to grow a new kidney in a petri dish, repair damaged nerve cells, or reverse memory loss.

Continuing a commitment to advance medicine through forward-thinking approaches and groundbreaking discoveries, the Icahn School of Medicine at Mount Sinai is announcing the creation of the Institute for Regenerative Medicine to foster innovative research into new pathways to cure a host of diseases from leukemia to Alzheimer’s disease, breast cancer, and airway diseases—with the promise of improving medical care, quality of life, and longevity for all patients.

The Institute will advance and coordinate research and training in broad areas of regenerative biology and medicine across the basic science and clinical departments at Mount Sinai, and will encompass three centers that each focus on a subset of diseases and disorders. The Institute will include the Alper Center for Neural Development and Regeneration, the Center for Epithelial and Airway Biology and Regeneration, and the Center for Advancement of Blood Cancer Therapies.

“The Institute for Regenerative Medicine is dedicated to making transformations in how we treat regenerative diseases that impact millions of lives,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “Clinicians, scientists, and researchers from across Mount Sinai will continue to leverage expertise and discoveries in human biology and regenerative medicine, rapidly translating our findings to improve care and treatment for some of the most crippling developmental and degenerative conditions that impact our patients.”

Alper Center for Neural Development and Regeneration

Researchers, scientists, and clinicians at the Alper Center for Neural Development and Regeneration, which is co-sponsored by The Friedman Brain Institute, are expanding our knowledge and understanding of the brain, its development, and its role in disease. By using innovative research techniques including cell cultures, animal models, and human tissue studies, the scientists are seeking new insights into the workings of the nervous system, identifying new ways to prevent and treat brain disorders—and ultimately transforming the field of regenerative medicine for these devastating illnesses.

“The future of regenerative medicine for brain disorders lies in understanding how the brain develops and maintains itself throughout life,” said the Center’s Director, Nan Yang, PhD, Associate Professor of Neuroscience at Icahn Mount Sinai. “Our goal is to advance research on models of human disease and identify new preventive and therapeutic strategies that can lead to cures or relief for conditions such as neurodevelopmental disorders and neurodegeneration including autism, epilepsy, Parkinson’s, Alzheimer’s, and multiple sclerosis.”

Center for Epithelial and Airway Biology and Regeneration

The Center for Epithelial and Airway Biology and Regeneration, co-sponsored by the Institute for Airway Science, is fostering collaboration among scientists who treat diseases of epithelial tissues including the skin, lung, trachea, oral cavity, breast, liver, stomach, intestine, and esophagus. These conditions include sinus disorders, lung injury, tracheal and lung transplants, breast cancers, severe asthma, eczema, psoriasis, and hair loss. The scientists will advance research related to epithelial development, stem cells, regeneration, and disease. The Center will also offer pilot grant funding for innovative and collaborative research projects, and provide a formal ground for basic, translational, and clinical researchers to collaborate and promote their study findings for application in clinical settings.

“The Center for Epithelial and Airway Biology and Regeneration defines translational research. This unique cross-section of basic and clinical scientists provides a platform to tackle vexing clinical problems and offer real solutions,” said the Center’s Clinical Director, Eric Genden, MD, Isidore Friesner Professor and Chair of Otolaryngology – Head and Neck Surgery for the Mount Sinai Health System and Icahn Mount Sinai. “The Center promises to bring basic scientific discovery to the patient bedside and promote novel therapies for the benefit of our patients.” The Scientific Directors of the Center are Ya-Wen Chen, PhD, Assistant Professor of Otolaryngology and Cell, Developmental and Regenerative Biology, and Elena Ezhkova, PhD, Professor of Cell, Developmental and Regenerative Biology and Dermatology.

Center for Advancement of Blood Cancer Therapies

The Center for Advancement of Blood Cancer Therapies, co-sponsored by The Tisch Cancer Institute, is dedicated to the study of childhood and adult blood cancers and the development of new treatments, including conventional drugs and cell therapies. Of particular focus are human models of hematopoiesis and leukemia based on induced pluripotent stem cells and primary blood cells, combined with gene editing and single-cell technologies.

“This new Center brings together investigators with a commitment to blood research that directly aims to uncover mechanisms of human blood diseases such as adult and pediatric leukemias and myelodysplastic syndrome, and develop new therapeutics,” said Eirini Papapetrou, MD, PhD, Director of the Center for Advancement of Blood Cancer Therapies and Professor of Oncological Sciences at The Tisch Cancer Institute, a part of the Tisch Cancer Center at Mount Sinai. “Our researchers will capitalize on recent breakthroughs that have transformed the capabilities of experimentation with human cells, and the Center will foster close relationships between researchers and clinicians. We will continually identify new areas of synergy and encourage these interactions towards clinical translation of new findings emerging from labs affiliated with the Center.”

The Institute for Regenerative Medicine will also now house the Black Family Stem Cell Institute, founded at Mount Sinai in 2005 to integrate research in embryonic stem cells and adult stem cell biology. It will continue to promote research in stem cell biology to accelerate translation that improves care for patients in clinical settings, such as development of new drugs and cell-based therapies that are tested for safety and efficacy. Sarah E. Millar, PhD, who leads the Black Family Stem Cell Institute, will serve as the Director of the Institute for Regenerative Medicine.

“The broader platform of the Institute for Regenerative Medicine will enable us to expand research beyond stem cell-based therapies to other aspects of regenerative medicine including ex vivo development of human tissues for disease modeling, drug screening, and transplantation; approaches to prevent and treat neurodevelopmental and neurodegenerative diseases; new methods to promote regeneration of epithelial tissues such as skin, hair and lung; and blood cancer research,” said Dr. Millar, Senior Associate Dean for Basic Research and Lillian and Henry M. Stratton Professorial Chair of Cell, Developmental and Regenerative Biology at Icahn Mount Sinai. “Our aim is to accelerate innovation by integrating and synergizing these efforts across Mount Sinai’s campus and by providing an exciting, welcoming, diverse, and inclusive intellectual environment.”

Michael Rendl, MD, Professor of Cell, Developmental and Regenerative Biology and Associate Director of the Black Family Stem Cell Institute, will serve as Associate Director of the Institute of Regenerative Medicine.

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.

Ranked No. 14 nationwide in National Institutes of Health funding and in the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 34 academic departments and 44 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, and gastrointestinal and liver diseases.

Icahn Mount Sinai offers highly competitive MD, PhD, and master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. In addition, more than 535 postdoctoral research fellows are in training within the Health System.

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into health care products and services that benefit the public.

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

——————————————————-

  • Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.


####

Convergent Dental Secures $50M of Growth Capital


Convergent Dental

This latest infusion of capital will accelerate our vision of driving the broad-based adoption of Solea® and is expected to fully finance the company to profitable growth and beyond.

Convergent Dental, Inc. (the “Company”), the power behind the Solea® All-Tissue Dental Laser, today announced that the Company entered into a new credit facility of $40 million with Trinity Capital Inc. (NASDAQ: TRIN), a leading provider of diversified financial solutions to growth-stage companies. The Company has drawn $20 million at closing, and has the option to draw an additional $20 million, subject to the conditions under the agreement.

The Company also announced $10 million of equity financing led by existing investors Arboretum Ventures and Gund Investment, LLC, including $5 million of new equity and $5 million of existing investor notes converted to equity at the close. “This latest infusion of capital will accelerate our vision of driving the broad-based adoption of Solea® and is expected to fully finance the company to profitable growth and beyond,” said Robert L. Gershon, CEO of Convergent Dental.

Solea® is an all-tissue CO2 dental laser solution that uniquely enables dentists to perform virtually anesthesia-free, blood-free, and pain-free procedures. Convergent Dental unites this novel technology with success support, giving dentists the ability to elevate and expand their practices through improved efficiency, patient experience, and clinical effectiveness.

“We are proud to partner with the Convergent Dental team,” said Lauren Cosentino, Managing Director, Life Sciences of Trinity. “Solea brings exciting innovation to dentistry, allowing doctors to provide pain-free, patient centric care and we look forward to supporting their continued growth.”

Piper Sandler served as financial advisor to Convergent Dental on the transaction.

About Convergent Dental

Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company’s flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists can rely on. Solea® is a true breakthrough in dental laser technology that offers a completely different experience for both dentists and patients when compared to traditional instruments or any earlier laser treatment. Solea® enables increased new patient flow, better clinical outcomes, significant efficiency gains, and new procedures. Follow the company Instagram, Facebook, and LinkedIn.

About Trinity Capital Inc.

Trinity Capital Inc. (Nasdaq: TRIN, TRINL), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital’s investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equipment financings and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience, and track record in lending to growth stage companies. For more information, please visit the Company’s website at http://www.trinitycap.com.

Share article on social media or email:

An Encouraging Autobiographical Story of Hope in the Face of Illness


News Image

I believe Holy Spirit laid it on my heart about 15 years ago that one day I would write a book about my experiences with chronic disease/illness, especially focusing on the invisibility of it all…

Author Erin Leopold motivates readers to never give up by sharing her own powerful story in Finding My Second Wind: Running Through Difficult Pain Finishing Strong with Warrior Faith ($17.49, paperback, 9781662872686; $8.99, e-book, 9781662872693).

When an invisible illness shook her world, Leopold, an athlete, had two options; wallow in self-pity or explore a deeper faith and hope in God. As her inspiring memoir thoughtfully shares, she used her heart of an athlete, courageously trusting in God. Leopold shares her personal journey of healing her spirit, soul, and body from a long struggle with chronic disease and how she partnered with God to achieve complete healing. Relatable with many readers, her road was not smooth so her faith and endurance faced bumps in the road while facing seemingly impossible obstacles. Leopold aims to help readers to never give up, by equipping them to become the most excellent version of who God destined them to be.

When asked what inspired the author to write this book, Leopold said, “I believe Holy Spirit laid it on my heart about 15 years ago that one day I would write a book about my experiences with chronic disease/illness, especially focusing on the invisibility of it all. Suffering is painful when what your life circumstances show do not match up to your physical condition. My heart aches for others dealing with Lyme disease.”

Erin Leopold holds a BA in Elementary Education. She is a fitness trainer, group exercise teacher, a wellness coach for 37 years, ACE certified in group exercise, APFA certified in holistic nutrition, a personal trainer in cardiac rehab/medical fitness for 8 years and holds other specialty certifications. She and her husband reside in South Carolina and love living in close proximity to beaches and mountains. Happiest in nature, she loves being active in God’s spectacular outdoor playground. She is passionate about living a life of purpose and sharing positive and encouraging messages of hope to her friends and community. She describes herself as having a competitive spirit. She is not good at being still. She loves spending time in the presence of the Lord, studying His Word and listening to great Bible teaching podcasts while she cycles or runs. You can follow Leopold on Facebook at Erin Dobb Leopold and erinleopold12 on Instagram.

###

Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 15,000 titles published to date. Finding My Finding My Second Wind: Running Through Difficult Pain Finishing Strong with Warrior Faith is available online through

Share article on social media or email:

Even When You Feel Small And Unimportant, God Is Mighty and Powerful


News Image

I believe men and women, single or married would be interested in my book. It gives personal experiences of how God changed my life completely, even when I had low self-esteem and felt I was not good enough for God to use me

Author Barbara Bean testifies to the mighty work of God in her life in I’m Not Supposed To Be Here But God ($12.49, paperback, 9781662874284; $5.99, e-book, 9781662874291).

Through God’s blessing in the ministry of help, Evangelist Bean feels deep compassion for the lost and hurting in the Body of Christ and wants to serve the community as the Lord leads and empowers.

“I believe men and women, single or married would be interested in my book. It gives personal experiences of how God changed my life completely, even when I had low self-esteem and felt I was not good enough for God to use me,” said Bean.

Evangelist Barbara Bean was called to the ministry in April 1969 and has ministered on skid row, boy’s camps, women’s prison, convalescent homes, television, radio, ministering in the Virgin Islands, Freeport Haiti, as well as locally. She is the founder and CEO of Outreach/Breakthrough Ministries, established in 1975. Bean graduated from Sure Foundation Theological Institute with a Bachelor of Theology Degree, a Master’s Degree in Theology, and an Ecclesiastical Doctorate Degree in Bible Philosophy in Theology. She and her husband, Elder Leslie Bean, share five adult children.

###

Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 15,000 titles published to date. I’m Not Supposed to Be Here But God is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.

Share article on social media or email:

The Ultimate ZBrush Experience Returns To Hollywood This Fall


ZBrush Summit 2023

The four-day event will stream live, offering an engaging, real-time online experience where attendees all over the world can interact with a global community from a diverse cross-section of industries.

Maxon, developers of professional software solutions for editors, filmmakers, motion designers and visual effects artists, is pleased to announce that registration is now open for The ZBrush Summit 2023, the premier event for digital sculpting and art. The event’s return to an in-person format also marks its 10th anniversary. Hosted by the Maxon team, the event will take place in Hollywood, CA and virtually from September 28th to October 1st, 2023. The four-day event will stream live, offering an engaging, real-time online experience where attendees all over the world can interact with a global community from a diverse cross-section of industries.

The event will take place at the Gnomon School of Visual Effects, conveniently located in Los Angeles (adjacent to Hollywood) at 1015 North Cahuenga Blvd. The event will feature:

Artist Insights

Attendees gain access to exclusive presentations by renowned digital artists and industry leaders from around the world. Highlights include detailed procedures and industry specific pipeline applications of ZBrush. Live Q&A sessions provide a rare opportunity for attendees to interact with and receive feedback from their favorite artists. This unique experience empowers artists while elevating their sculpting skills and knowledge.

Live ZBrush Sculpt-off

The live ZBrush Sculpt-Off is the world’s most prestigious digital sculpting competition. Bringing together the best digital sculptors from diverse backgrounds and international pedigree. Competitors go head-to-head in front of a live and streaming audience to create masterpieces aligned with a given prompt while trying to complete their work within a set time limit. Bare witness to the power of ZBrush as digital sculptors showcase their speed and creativity in their quest to be crowned champion.

Creative Lifestyle

The Creative Lifestyle segment at the ZBrush Summit provides attendees a unique opportunity to see the creative process in action and to gain insight into the tools and techniques used by leading digital artists. The workshops may cover a range of topics, such as concept art, character design, and 3D printing, among others. Attendees will have the chance to ask questions and interact with industry luminaries and experience an immersive and enriching environment meant to inspire creativity and encourage artists to push the boundaries of their own artistic abilities.

Registration for the event is now open at zbrushsummit.com. Whether attending in person or virtually, the ZBrush Summit will be the ultimate experience for digital sculpting and art enthusiasts.

About Maxon

Maxon makes powerful, yet approachable software solutions for content creators working in 2D and 3D design, motion graphics, visual effects and visualization. Maxon’s innovative product portfolio helps artists supercharge their creative workflows. Our product lines include the award-winning Cinema 4D suite of 3D modeling, simulation and animation technology; the creativity-on-the-go Forger mobile sculpting app; the diverse Red Giant lineup of revolutionary editing, motion design and filmmaking tools; the leading-edge, blazingly fast Redshift renderer; and ZBrush, the industry-standard digital sculpting and painting solution.

Maxon’s team is comprised of fun, passionate people who believe in building and empowering a successful artistic community. From our popular, inclusive events to our free Cineversity educational resources, Maxon recognizes that developing strong connections with creatives and fostering their professional growth is integral to our ability to stay on top of industry trends and better serve customers. Maxon is part of the Nemetschek Group.

Share article on social media or email:

Upper Path Recovery Opens New Outpatient Addiction Treatment Center in Woodland Hills, California


Our team of addiction specialists is dedicated to providing compassionate care and customized treatment plans to help our clients achieve lasting recovery.

Located in the heart of Woodland Hills, Upper Path Recovery’s new facility offers a warm and welcoming environment for those struggling with addiction. The treatment center is staffed with experienced and professional addiction specialists who provide evidence-based treatments to help individuals achieve long-term recovery.

“We are thrilled to open our new facility in Woodland Hills and offer our proven addiction treatment programs to the community,” said Upper Path Recovery’s CEO. “Our team of addiction specialists is dedicated to providing compassionate care and customized treatment plans to help our clients achieve lasting recovery.”

Upper Path Recovery’s IOP program offers intensive treatment that allows individuals to receive comprehensive care while still being able to maintain their daily routines. PHP is a more structured program that provides individuals the necessary support to transition from a higher level of care to outpatient treatment. The standard outpatient program offers flexible scheduling and ongoing support for those who have completed a higher level of care. The sober living program provides a supportive and structured environment for those who are in early recovery and need a safe place to transition back into their everyday lives. Sober living is also available to those participating in outpatient treatment programs but lacks a home environment conducive to recovery.

The new facility is equipped with state-of-the-art amenities, including comfortable patient rooms, private therapy rooms, and a spacious community area for group therapy sessions. Upper Path Recovery’s team of addiction specialists includes licensed therapists, psychiatrists, and certified addiction counselors who work together to provide a multidisciplinary approach to addiction treatment.

Upper Path Recovery is now accepting new clients at its Woodland Hills location. For more information about the treatment programs offered, please visit https://upperpathrecovery.com/ or call (818)-748-4845.

About Upper Path Recovery:

Upper Path Recovery is a leading addiction treatment provider that offers comprehensive and personalized care to individuals struggling with addiction. By providing evidence-based treatment programs, including IOP, PHP, standard outpatient programs, and sober living, Upper Path Recovery’s mission is to help clients achieve long-term recovery.

Their team of addiction specialists includes licensed therapists, psychiatrists, and addiction counselors who work together to provide a multidisciplinary approach to addiction treatment.

For more information, please visit https://upperpathrecovery.com/ or call (818)-748-4845.

Share article on social media or email:

New Partnership with National Fatherhood Initiative® to Support Virginia Department of Behavioral Health and Developmental Services in Serving Fathers


Logo for National Fatherhood Initiative

“Collaborating with National Fatherhood Initiative® to bring the evidence-based 24:7 Dad® program to the fathers we serve will have a positive, lasting impact on hundreds of fathers and families across Virginia,” said Glenda Knight, Women’s Services Coordinator for the Virginia DBHDS.

National Fatherhood Initiative (NFI)®, the nation’s leading fatherhood organization, and the Virginia Department of Behavioral Health and Developmental Services (DBHDS) have embarked on a new partnership to implement 24:7 Dad®, the most widely used evidence-based fatherhood program in the U.S., in DBHDS-licensed community services boards across the state. This is DBHDS’ first father-focused departmental initiative.

Healthy father involvement is associated with better outcomes on nearly every measure of child well-being. Many factors influence a father’s ability to be involved in his child’s life, including trauma, mental illness, and addiction. DBHDS intends to more intentionally serve fathers who are accessing behavioral health services—alone or with a co-parent—by providing evidence-based programming designed to help fathers establish strong foundations for their families.

24:7 Dad® is NFI’s flagship evidence-based fatherhood program. The program is used by hundreds of U.S. organizations to train fathers to be involved, responsible, and committed 24 hours a day, 7 days a week. In January 2023, 47 DBHDS staff participated in a two-day webinar where they were trained in facilitating 24:7 Dad®. Trainees represented 10 DBHDS community services boards—each covering 5-8 Virginia counties—and their associated Project LINK programs. 24:7 Dad® will be integrated into this network of programs throughout 2023 and be delivered by clinicians, case managers, and peer recovery specialists.

DBHDS promotes dignity, choice, recovery, and the highest possible level of participation in work, relationships, and community life for individuals with mental illness, developmental disabilities, or substance-use disorders. The agency partners with 40 locally run community services boards to provide a comprehensive suite of evidence-based behavioral health and prevention services. Embedded within many of the community services boards are Project LINK programs, which coordinate services to address the specific needs of women and infants impacted by substance-use disorders. Several Project LINK programs provide direct services to men, such as case management and parenting education.

“Although co-ed parenting programs are beneficial to parents and caregivers, it is important to recognize the unique needs of fathers and allow fathers and caregivers to support each other on their parenting journey,” said Glenda Knight, Women’s Services Coordinator for the Virginia Department of Behavioral Health and Developmental Services. “That’s why we chose to collaborate with National Fatherhood Initiative® to bring the evidence-based 24:7 Dad® program to the fathers we serve. I firmly believe that our partnership will have a positive, lasting impact on fathers and families across Virginia.”

NFI comes alongside human services organizations and practitioners with a strengths-based approach to father engagement training, evidence-based and evidence-informed fatherhood programs, and other educational materials to help them be more father-inclusive. In addition to developing parent education skills, fathers who participate in the organization’s 24:7 Dad® program encourage other dads to take care of themselves so they can care for and be there for their children. Building resiliency, developing pro-fathering attitudes, and knowing where to get support can reduce the risk of child maltreatment.

“NFI is thrilled to assist the Virginia Department of Behavioral Health and Developmental Services in its efforts to engage fathers in our 24:7 Dad® program,” said Christopher Brown, President of National Fatherhood Initiative®. “Integrating the program in behavioral health treatment settings—both in the commu- nity and at home—presents a unique opportunity to champion fatherhood and provide direct support to fathers to help them be the type of dad they want to be for their children. This is just the beginning of what we hope will be a long-term partnership.”

For more information on NFI, visit http://www.fatherhood.org. More information on the DBHDS can be found at dbhds.virginia.gov/.

###

About National Fatherhood Initiative

National Fatherhood Initiative (NFI) was founded in 1994 to reverse our nation’s destructive trend toward father absence. Today, nearly 20 million American children live in homes where their biological fathers do not live. Yet, the fact remains that millions of families interact with human-service organizations every year that are primarily mother-focused. Therefore, NFI’s mission is to increase father involvement by equipping human service organizations and communities with the father engagement training, programs, and resources they need to be father-inclusive. Our vision is that all human service organizations and communities are proactively father-inclusive so that every child has an involved, responsible, and committed father in their lives.

Accordingly, we accomplish our mission by:

  • Educating all Americans, especially fathers, through social media, earned media, research, and free resources.
  • Equipping organizations and communities with fatherhood programs and resources and through training, planning, and technical assistance services.
  • Engaging and assisting organizations and communities to mobilize at the micro- and macro-level to increase fathers’ involvement in children’s lives.

For more information on NFI, visit http://www.fatherhood.org.

Share article on social media or email:

Data Stitching to Streamline Life Science Data for Visualization, Auditing, and Machine Learning


Scispot

“Scispot GLUE offers the opportunity to unlock that potential by seamlessly connecting disparate systems and enhancing data utilization,” said Mark Adams, COO of Adaptive Biotechnologies.

Scispot, the creator of the best tech stack for modern biotech and pharma, is excited to announce the launch of Scispot GLUE™. This revolutionary data stitching platform is designed specifically for lab informatics teams. It is set to transform the biotech and pharma industries by eliminating data silos and making data audit-ready, visualization-friendly, and machine learning-ready.

GLUE automates the data extraction, transformation, and preparation process, making it an essential tool for modern life science companies dealing with internal data graveyards and disconnected systems. The platform seamlessly extracts data from various sources, such as Benchling, spreadsheets, Notion, Google Drive, One Drive, GCS, Azure Blobs, traditional Electronic Lab Notebooks (ELNs), Laboratory Information Management Systems (LIMS), and even an organization’s legacy systems. Additionally, GLUE’s robust data transformation capabilities are tailored to the specific needs of biotech and pharma informatics.

“We are incredibly excited to launch GLUE, a powerful data stitching toolkit that will revolutionize the way lab R&D and informatics teams harness the full potential of their data. With GLUE, our vision is to eradicate data silos and transform data graveyards into treasure troves of knowledge, ultimately advancing life science R&D to new levels,” said Guru Singh, founder & CEO of Scispot.

Scispot GLUE’s key features include connectors (e.g., Benchling connector) to extract data, a transformation toolkit to cleanse and process data, Jupyter Hub to manipulate and analyze data, and more. The pre-built visualization templates enable quick data visualization, uncovering valuable insights that drive accelerated R&D decisions. The platform also generates compliance reports automatically, simplifying the process of meeting regulatory requirements.

As the first trusted connector linking Benchling with modern data pipelines while generating key insights on the Scispot platform, GLUE represents a significant advancement in data management for the life sciences industry. Scispot is the world’s first scientific platform built with a computational persona in mind, and with the introduction of GLUE, the company continues to improve the way biotech and pharma organizations manage their data.

“The vast potential locked within biotech data has often remained untapped due to siloed data locked in closed systems. Scispot GLUE offers the opportunity to unlock that potential by seamlessly connecting disparate systems and enhancing data utilization,” said Mark Adams, COO of Adaptive Biotechnologies and CDL Advisor.

Scispot is not affiliated with, endorsed by, or in partnership with Benchling, and Scispot GLUE offers an unofficial connector for Benchling. For more information about Scispot GLUE or to request a demo, visit http://www.scispot.com/scispot-glue.

ABOUT SCISPOT

Scispot is a Y Combinator-backed life science informatics company based in the Kitchener-Waterloo area. Scispot has created the best tech stack to help modern biotechs evolve into efficient, scalable TechBio companies. Scispot’s toolkit makes biotech R&D templatizable and programmable, enabling companies to automate lab management, centralize data, establish repeatable workflows, and comply with regulatory guidelines. To learn more, please visit http://www.scispot.com.

Share article on social media or email:

Inspired by Tragedy, Military Vet Donates Glasses for Color Blindness to Rio Rancho Schoolchildren Who Are Color Vision Deficient


“One of my colleagues injured in the blast had a son who was deaf and received cochlear implants, which completely changed his life. This inspired me to help others, so every year I buy EnChroma glasses to help color blind students in the Rio Rancho Public School District.” – Ron Neldon

– Generous Donation Helps Color Blind Students Overcome Learning Challenges in School –

Rio Rancho, NM & Berkeley, CA – April 24, 2023 – EnChroma, Inc. – makers of glasses for color blindness – and Rio Rancho Public Schools, today announced that a generous local military veteran has purchased EnChroma glasses for color blind students to overcome the obstacles color blindness poses to learning. The EnChroma glasses will help the color blind students better understand color-coded information on tests, projects, or assignments for which correctly interpreting color plays a role.

One in 12 boys (8%) and one in 200 girls (.5%) are red-green color blind; an estimated 13 million in the US and 350 million worldwide. With nearly 17,000 students in the district, over 700 Rio Rancho students are likely color blind.

While people with normal color vision see over one million hues and shades, the color blind only see an estimated 10% of them. As a result, colors can appear dull, indistinct, and difficult to discern. This can make understanding colored information in graphs, charts, presentations, maps, and material written in certain colors problematic. Click here to see how schoolwork containing colors appear to red-green color blind students.

The donor of the glasses, Ron Neldon, is motivated by both tragedy and a unique inspiration. On June 25, 1996, terrorists backed by Iran detonated a truck bomb outside of the Khobar Towers housing complex in Saudi Arabia, where Ron was stationed with the Air Force. The blast killed 19 US service members and injured hundreds. On behalf of the victims, the US government successfully sued Iran for its role. With some of the money he received from the settlement, Ron has sought ways to help others.

“One of my colleagues injured in the blast eventually had a son who was born deaf and received cochlear implants so he could hear, which completely changed his life,” said Neldon. “I started watching videos of people hearing for the first time and eventually became fascinated by people seeing color for the first time with EnChroma glasses. They inspired me to make a positive impact on young people’s lives, so every year I buy EnChroma glasses to help color blind students in the Rio Rancho Public School District.” To read more about Neldon’s experience and motivation to help others, or to download his photo, click here.

Engineered with special optical filters, EnChroma glasses help those with red-green color blindness see an expanded range of colors more vibrantly, clearly, and distinctly.

“Only 11 of 50 states currently test schoolchildren for color blindness, so many kids go undiagnosed through much of their education unaware of their condition or its effects,” said Erik Ritchie, CEO of EnChroma. “We applaud the generosity of Mr. Neldon, thank him for his service, and encourage other school districts to test for color vision deficiency and get EnChroma glasses to support color blind students.”

EnChroma Color Accessibility Program™

EnChroma is the lead advocate for “color accessibility” through its EnChroma Color Accessibility Program™. Via the program, EnChroma donates a pair of glasses for each pair purchased by public venues. In New Mexico, EnChroma glasses have been offered since 2019 to color-blind visitors to the Georgia O’Keeffe Museum in Santa Fe to enable them to experience the colors in O’Keeffe’s iconic works.

Over 200 organizations participate in the program including schools, universities, parks, libraries, museums, and others to loan the glasses to color-blind students and guests. In addition to its free color blindness test, EnChroma offers materials for schools to share with teachers, parents, and students to educate them about color blindness and how to support color-blind students. The program is also open to employers.

EnChroma encourages parents and educators to have students take EnChroma’s free online color blindness test at enchroma.com, which takes less than two minutes. A study by the University of California, Davis, and France’s INSERM Stem Cell and Brain Research Institute, demonstrated the effectiveness of EnChroma glasses.

Media: Product shots, b-roll, videos, and images can be downloaded here. EnChroma’s CEO, and Rio Ranch Public Schools officials, are available for interviews.

About Rio Rancho Public Schools

Rio Rancho Public Schools is a school district based in Rio Rancho, New Mexico, serving the municipality of Rio Rancho. The school district has a total of 20 schools and nearly 17,000 students. The district has two high schools, two alternative high schools, four middle schools, 11 elementary schools, and one preschool.

Visit http://www.rrps.net or call 505.896.0667 for more information.

About EnChroma

Based in Berkeley, Calif., EnChroma produces leading-edge eyewear for color blindness and low vision, and other solutions for color vision, sold online and through Authorized Retailers worldwide. Invented in 2010, EnChroma’s patented eyewear combines the latest in color perception, neuroscience, and lens innovation to improve the lives of people with color vision deficiency around the world. EnChroma received an SBIR grant from the National Institutes of Health (NIH). It earned the 2016 Tibbetts Award from the U.S. Small Business Administration in recognition of the firm’s innovative impact on the human experience through technology, and the 2020 Innovation Award in Life Sciences from the Bay Area’s East Bay Economic Development Alliance.

For more information call 510-497-0048 or visit http://www.enchroma.com/enchroma.com.

Media Contacts:

Rio Rancho Public Schools

Wyndham Kemsley

Communications Director

Phone: 505.614.6872

wyndham.kemsley@rrps.net

EnChroma

Kent Streeb

Vice President of Communications and Partnerships

P: 530.908.9225

kent@enchroma.com